DEFA14A: Enhabit to Go Private in Kinderhook Acquisition

Enhabit, Inc. announced an agreement to be acquired by private investment firm Kinderhook Industries, transitioning to a privately held company.

Summary

• Enhabit, Inc. has entered into an agreement to be acquired by Kinderhook Industries, a private investment firm focused on building strong industry leaders in healthcare services.
• The transaction is expected to close in the second quarter of 2026, subject to customary conditions and approvals.
• Upon completion, Enhabit will become a privately held company and will no longer be listed on the New York Stock Exchange.
• The company will continue to operate under the Enhabit name and brand post-acquisition.
• A town hall video will be shared later this week to provide more context regarding this announcement.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive strategic move for Enhabit, offering enhanced resources and long-term investment flexibility under private ownership, though subject to customary closing conditions and associated M&A risks.

Positives

• Kinderhook's investment reflects the strength of Enhabit's business and the value created by its employees.
• The partnership is expected to provide access to additional resources and expertise, supporting continued growth, strengthening clinical capabilities, and expanding access to high-quality home health and hospice services.
• Operating as a private company is anticipated to offer greater flexibility for long-term investment in people, clinical programs, tools, and resources.
• Management believes this next chapter will create more opportunities for the Enhabit team as the business grows.
• The company highlights a successful history of growth and employee investment during a previous decade under private equity support for Encompass Home Health and Hospice.

Risks

• The proposed transaction may not be completed in a timely manner or at all, which could adversely affect Enhabit's business and the price of its common stock.
• Failure to satisfy any of the conditions to the consummation of the transaction, including the receipt of certain regulatory approvals.
• Failure to obtain stockholder approval of the proposed transaction.
• The occurrence of any fact, event, change, development, or circumstance that could give rise to the termination of the transaction agreement, potentially requiring Enhabit to pay a termination fee.
• The announcement or pendency of the proposed transaction could affect Enhabit's business relationships, operating results, and business generally.
• The proposed transaction may disrupt Enhabit's current plans and operations.
• Challenges in retaining and hiring key personnel and maintaining relationships with key business partners, customers, and others.
• Diversion of management's attention from ongoing business operations.
• Unexpected costs, charges, or expenses resulting from the proposed transaction.
• The ability of Anchor Parent, LLC to obtain financing for the proposed transaction.
• Potential litigation relating to the proposed transaction that could be instituted against the parties or their respective directors, managers, or officers.
• Continued availability of capital and financing.
• Certain restrictions during the pendency of the proposed transaction that may impact Enhabit's ability to pursue certain business opportunities or strategic transactions.
• Other risks described in Enhabit's filings with the SEC, including its Annual Report on Form 10-K filed on March 6, 2025, and subsequent filings.

Future Outlook

Enhabit expects to have access to additional resources and expertise with Kinderhook's support, enabling continued growth, strengthened clinical capabilities, and expanded access to home health and hospice services. Operating as a private company is anticipated to provide greater flexibility for long-term investment in people, clinical programs, and supporting tools and resources.

Management Comments

• "I'm pleased to share important and exciting news." Barb Jacobsmeyer, President and CEO.
• "Kinderhook's investment in Enhabit reflects the strength of our business and the value our employees have created over many years." Barb Jacobsmeyer, President and CEO.
• "We believe this partnership positions Enhabit well for the future." Barb Jacobsmeyer, President and CEO.
• "We expect that operating as a private company will give us greater flexibility to invest for the long term." Barb Jacobsmeyer, President and CEO.
• "Ultimately, we expect that this next chapter will create even more opportunities for the Enhabit team as we grow our business." Barb Jacobsmeyer, President and CEO.
• "Until then, nothing changes. We will continue to operate as an independent public company, and I ask that you remain focused on what you do best: providing compassionate, high-quality care to our patients." Barb Jacobsmeyer, President and CEO.
• "We are confident this next chapter with Kinderhook will be the best one yet." Barb Jacobsmeyer, President and CEO.

Industry Context

StockSavvy.ai notes that the acquisition of Enhabit by Kinderhook Industries reflects a broader trend in the healthcare services sector, where private equity firms are increasingly investing in home health and hospice providers. This trend is driven by the growing demand for cost-effective, in-home care solutions and the potential for operational efficiencies and market consolidation under private ownership.

Legal Proceedings

• Potential litigation relating to the proposed transaction that could be instituted against the parties to the transaction agreement or their respective directors, managers or officers.

Stakeholder Impact

• Shareholders: Will receive consideration for their shares as the company transitions to private ownership, ceasing to hold publicly traded stock.
• Employees: Expected to have more opportunities as the business grows, with plans for long-term investment in people, clinical programs, tools, and resources; however, there are risks related to retaining and hiring key personnel and potential diversion of management's attention.
• Patients/Customers: Expected to benefit from strengthened clinical capabilities and expanded access to high-quality home health and hospice services.
• Business Partners: Risks related to maintaining relationships with key business partners in light of the proposed transaction.

Next Steps

• The transaction is expected to close in the second quarter of 2026.
• Enhabit will share a town hall video later this week to provide more context.
• Enhabit expects to announce a special meeting of stockholders as soon as practicable to obtain stockholder approval of the proposed transaction.
• Enhabit intends to file relevant materials with the SEC, including a proxy statement in preliminary and definitive form.

Key Dates

Recommendation

The announcement of Enhabit's acquisition by Kinderhook Industries implies a fixed acquisition price for shareholders, making significant further price appreciation unlikely. Investors should hold their shares until the transaction closes to realize the acquisition value, or consider selling if they prefer immediate liquidity, factoring in the standard risks associated with M&A completion.

Keywords

Enhabit, Kinderhook Industries, Acquisition, Home Health, Hospice, Healthcare Services, Private Equity, Merger, Delisting, EHC